Showing 701-710 of 2876 results for "".
- New Artificial Intelligence Platform to Enhance Leads, Conversions, and Retention for Private-Pay Clinicshttps://modernaesthetics.com/news/new-artificial-intelligence-platform-to-enhance-leads-conversions-and-retention-for-private-pay-clinics/2475367/BoomerangFX announced the global launch of LeadEngineAITM, an AI-powered platform designed to streamline and automate lead generation and conversion for private-pay healthcare clinics. A press release from the manufacturer said that the tool integrates marketing automation, CR
- skinbetter science® Launches Even Intensive Skin Tone Correcting Serumhttps://modernaesthetics.com/news/skinbetter-science-launches-even-intensive-skin-tone-correcting-serum/2475366/skinbetter science® has announced the launch Even Intensive Skin Tone Correcting Serum, an advanced discoloration treatment formulated to address persistent dark marks, uneven tone, and skin texture irregularities. According to
- Johnson & Johnson MedTech Launches Larger-Sized Breast Implants for Post-Mastectomy Reconstructionhttps://modernaesthetics.com/news/johnson-johnson-medtech-launches-larger-sized-breast-implants-for-post-mastectomy-reconstruction/2475365/Johnson & Johnson MedTech has announced the U.S. launch of MENTORTM Memory GelTM Enhanced Breast Implants, a new line of breast implants specifically developed for women undergoing primary or revision reconstruction after mastectomy. The implants, which received FDA appr
- Allergan Aesthetics Appoints Inaugural AMI Training Center Facultyhttps://modernaesthetics.com/news/allergan-aesthetics-appoints-inaugural-ami-training-center-faculty/2475356/Allergan Aesthetics, an AbbVie company, has introduced the first faculty cohort for its new Allergan Medical Institute® (AMI) Training Centers in Orange County, CA, and Atlanta, GA. The new AMI Training Center Faculty will lead immersive educational programs designed to train and support the next
- ASLMS 2025: E. Victor Ross, MD, Talks Landscape of Fractional Laser Treatmentshttps://modernaesthetics.com/news/aslms-2025-e-victor-ross-md-talks-landscape-of-fractional-laser-treatments/2475359/At the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, E. Victor Ross, MD, shared insights on the evolving role of fractional lasers in dermatologic practice, highlighting both their advantages and limitations. Risk, Recovery, and Pigmentatio
- ASLMS 2025: New Laser Platforms Expand Options for Vascular Rosaceahttps://modernaesthetics.com/news/aslms-2025-new-laser-platforms-expand-options-for-vascular-rosacea/2475358/Advanced vascular lasers are transforming the treatment of rosacea by targeting its root cause (chronic vascular dilation) rather than just managing inflammation. At the 2025 American Society for Laser Medicine and Surgery (ASLMS) Annual Meeting in Orlando, Eric Bernstein, MD, Director of
- Bausch Health Launches Fraxel FTX™ at ASLMS 2025https://modernaesthetics.com/news/bausch-health-launches-fraxel-ftx-at-aslms-2025/2475353/Bausch Health Companies Inc. and its aesthetics division, Solta Medical, have introduced Fraxel FTX™, the latest advancement in laser skin resurfacing, at the American Society for Laser Medicine & Surgery (ASLMS) 2025 Annual Conference in Orlando, FL. The launch marks the beginning of a natio
- Allergan Aesthetics Submits BLA for TrenibotulinumtoxinE for Glabellar Lineshttps://modernaesthetics.com/news/abbvie-submits-bla-for-trenibotulinumtoxine-for-glabellar-lines/2475351/Allergan Aesthetics, an AbbVie Company, has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), seeking approval for the treatment of moderate to severe glabellar lines. TrenibotE, a serotype E botulinum toxin
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://modernaesthetics.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- Global Experts Urge Return to ‘Natural Breast Beauty’ Amid Rise in Aesthetic Complicationshttps://modernaesthetics.com/news/global-experts-urge-return-to-natural-breast-beauty-amid-rise-in-aesthetic-complications/2475346/In response to rising rates of revision surgery and dissatisfaction with overly augmented results, an international coalition of leading plastic surgeons has introduced new framework for achieving more natural outcomes in breast augmentation. The Global Consensus on Natural Breast Beauty,